#13: The Machine: Generex Biotechnology Announces That An Investigators' Meeting Was Recently Held for Its Global Phase III Clinical Trial of Generex Oral-lyn
72 Clinical Centers to... |
February 10, 2008
07:30:02 AM |
#12: The Machine: Generex Biotechnology Receives Regulatory Approval to Initiate Phase III Clinical Trial for Generex Oral-lyn in First of the Global Locations Selected by the Company
Ministry of Health of the... |
January 29, 2008
02:23:40 AM |
#11: The Machine: Generex Biotechnology Announces Co-Authorship of Publications With Johns Hopkins University and Stallergenes S.A.
Studies
Demonstrate the... |
January 29, 2008
02:23:10 AM |
#10: The Machine: Generex Biotechnology Awarded Patent in Japan For Its Antigen Presentation Technology
WORCESTER, Mass., Dec. 18,... |
January 18, 2008
05:11:48 PM |
#9: The Machine: Generex Biotechnology Receives $400,000 Purchase Order for OTC Products From Middle Eastern Marketing Partner
WORCESTER, Mass., Dec. 13,... |
January 18, 2008
05:11:22 PM |
#8: NewsBot: Generex Biotechnology Announces Generex Oral-lyn Marketing Launch Activities Made by the Company's Marketing and Distribution Licensee in India
The Company's
Medical and Marketing Teams Making Presentations to Leading Indian... |
January 17, 2008
01:47:35 PM |
#7: Rocketrade: UPGRADE !
Generex Biotechnology "market outperform"Wednesday, January 16, 2008... |
January 16, 2008
11:31:06 PM |
#6: FastFun: Generex Biotechnology Makes Presentations At Latin-American Diabetes Congress and the Cuban Diabetes Conference
Generex Biotechnology Makes Three Podium Presentations and One Poster... |
November 20, 2007
10:01:18 PM |
#5: FastFun: Noted Wall Street Analyst Highlights Generex Biotechnology in Report
WORCESTER, Mass., Nov. 15, 2007 (PRIME NEWSWIRE) -- Generex... |
November 20, 2007
09:58:52 PM |
#4: FastFun: Generex Biotechnology CEO Featured in Fox Business Channel Interview
Company Executive Discusses Recent Approval to Sell Generex Oral-lyn in... |
November 20, 2007
09:58:02 PM |
#3: FastFun: First Prostate Cancer Patients Treated in a Phase I Clinical Trial as Part of a Collaboration Between Generex Biotechnology and the Saint Savas Cancer Hospital
WORCESTER, Mass., Nov. 5, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology... |
November 20, 2007
09:56:37 PM |
#2: FastFun: Generex Biotechnology Receives Regulatory Approval to Sell Generex Oral-lyn in India
Generex Oral-lyn Becomes First Non-Injectable Buccal Insulin Approved in India;... |
November 20, 2007
09:54:48 PM |
#1: Jason: GNBT: Generex Biotechnology Granted Patents in Canada and Europe
Company Expands Drug Delivery Platform Patent Portfolio in Canada and... |
March 17, 2007
08:29:32 AM |
| 
| 
| 
| 
| 
| 
